Vitenskapelig artikkel

• Kjetil Vikene; Geir Olve Skeie; Karsten Specht (2019). Compensatory task-specific hypersensitivity in bilateral planum temporale and right superior temporal gyrus during auditory rhythm and omission processing in Parkinson?s disease. (ekstern lenke)
• Christian Amdahl; Espen Homleid Alseth; Nils Erik Gilhus et al. (2007). Polygenic disease associations in thymomatous myasthenia gravis. (ekstern lenke)
• Yu Hong; Geir Olve Skeie; Paraskevi Zisimopoulou et al. (2017). Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms. (ekstern lenke)
• Fredrik Romi; Geir Olve Skeie; Johan Arild Aarli et al. (2000). Muscle autoantibodies in subgroups of myasthenia gravis patients. (ekstern lenke)
• Yu Hong; Hai-Feng Li; Fredrik Robert Romi et al. (2018). HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis. (ekstern lenke)
• Steven Paul Luckman; Geir Olve Skeie; Geir Helgeland et al. (2006). Morphological effects of myasthenia gravis patient sera on human muscle cells. (ekstern lenke)
• Maziar Behbahani; Geir Olve Skeie; Geir Egil Eide et al. (2019). A prospective study of the natural history of incidental meningioma-Hold your horses!. (ekstern lenke)
• Geir Olve Skeie; Alexandra Freburg; G Kolmerer et al. (1997). Titin transcript in thymomas. (ekstern lenke)
• Geir Olve Skeie; Fredrik Romi; Johan Arild Aarli et al. (2003). Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies. (ekstern lenke)
• Ole Tveiten; Geir Olve Skeie; Kristoffer Haugarvoll et al. (2013). Treatment in early Parkinson's disease: the Norwegian ParkWest study. (ekstern lenke)
• Fredrik Romi; Geir Olve Skeie; Johan Arild Aarli et al. (2000). The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. (ekstern lenke)
• Fredrik Romi; Geir Olve Skeie; Johan Arild Aarli et al. (2000). Muscle autoantibodies in subgroups of myasthenia gravis patients. (ekstern lenke)
• E Lübke; A Freiburg; Geir Olve Skeie et al. (1998). Striational autoantibodies in myasthenia gravis patients recognizw I-band titin epitopes. (ekstern lenke)
• Bernd Mueller; Jan Petter Larsen; Tore Wentzel-Larsen et al. (2011). Autonomic and sensory symptoms and signs in incident, untreated Parkinson’s Disease : frequent but mild. (ekstern lenke)
• Geir Olve Skeie; Slobodanka Apostolski; Amelia Evoli et al. (2010). Guidelines for treatment of autoimmune neuromuscular transmission disorders. (ekstern lenke)
• Geir Olve Skeie; Johan Arild Aarli; Nils Erik Gilhus (2006). Titin and ryanodine receptor antibodies in myasthenia gravis. (ekstern lenke)
• Yu Hong; Hai-Feng Li; Geir Olve Skeie et al. (2016). Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients. (ekstern lenke)
• Geir Olve Skeie; Bernd Mueller; Kristoffer Haugarvoll et al. (2010). Differential Effect of Environmental Risk Factors on Postural Instability Gait Difficulties and Tremor Dominant Parkinson's Disease. (ekstern lenke)
• Geir Olve Skeie; PK Lunde; OM Sejersted et al. (1998). Myasthenia gravis sera containing anti-ryanodine receptor antibodies inhibit binding of (3H-) ryanodine to sarcoplasmic reticulum. (ekstern lenke)
• Geir Olve Skeie; PK Lunde; OM Sejersted et al. (1998). Myasthenia gravis-associated ryanodine receptor antibodies inhibit binding of ryanodine to sarcoplasmic reticulum. (ekstern lenke)
• SP Luckman; Geir Olve Skeie; G Helgeland et al. (2004). Cytoxic Effects of Myasthenia Gravis Patient Sera on Primary Human Skeletal Muscle Cell Cultures. (ekstern lenke)
• Johan Arild Aarli; Nils Erik Gilhus; Fredrik R. Romi et al. (2009). Myasthenia gravis in the elderly. (ekstern lenke)
• Geir Olve Skeie; JP Pandey; Johan Arild Aarli et al. (1999). TNFB polymorphisms in myasthenia gravis. (ekstern lenke)
• Simon Ulvenes Kverneng; Sepideh Mostafavi; Yana Mikhaleva et al. (2025). Platelet mitochondrial complex I and IV activities are not reliable stratification biomarkers in Parkinson's disease. (ekstern lenke)
• Geir Olve Skeie; Bente Müller; Kristoffer Haugarvoll et al. (2013). Parkinson disease: Associated disorders in the Norwegian population based incident ParkWest study. (ekstern lenke)
• Geir Olve Skeie (2000). Skeletal muscle titin: physiology and pathophysiology. (ekstern lenke)
• Hanne Marie Bøe Lunde; Geir Olve Skeie; Anne Kjørsvik et al. (2012). Focal myositis - A neurogenic phenomenon?. (ekstern lenke)
• Bente Skeie; Geir Olve Skeie; Per Øyvind Enger et al. (2011). Gamma Knife Surgery of Colorectal Brain Metastases: A High Prescription Dose of 25 Gy May Improve Growth Control. (ekstern lenke)
• Kjetil Vikene; Geir Olve Skeie; Karsten Specht (2019). Subjective judgments of rhythmic complexity in Parkinson's disease: Higher baseline, preserved relative ability, and modulated by tempo. (ekstern lenke)
• Fredrik Romi; Geir Olve Skeie; Christian A. Vedeler et al. (2000). Complement activation by titin and ryanoidine receptor autoantibodies in myasthenia gravis. (ekstern lenke)
• Nils Erik Gilhus; Geir Olve Skeie; Fredrik Robert Romi et al. (2011). Myasthenia gravis autoantibodies have a target also outside the neuromuscular junction. (ekstern lenke)
• Johannes Jernqvist Gaare; Geir Olve Skeie; Charalampos Tzoulis et al. (2017). Familial aggregation of Parkinson's disease may affect progression of motor symptoms and dementia. (ekstern lenke)
• Ivar Otto Gjerde; Anette Storstein; Geir Olve Skeie et al. (1998). Ataksi på grunn av vitamin E-mangel. (ekstern lenke)
• Andreas O. Myking; Geir Olve Skeie; JE Varhaug et al. (1998). The histomorphology of the thymus in late onset, non-thymoma myasthenia gravis. (ekstern lenke)
• Fredrik Romi; Lars Bø; Geir Olve Skeie et al. (2002). Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with co-stimulatory molecules. (ekstern lenke)
• Håvard Torvik Gotaas; Geir Olve Skeie; Nils Erik Gilhus (2016). Myasthenia gravis and amyotrophic lateral sclerosis: A pathogenic overlap. (ekstern lenke)
• Kjetil Vikene; Geir Olve Skeie; Karsten Specht (2018). Abnormal phasic activity in saliency network, motor areas, and basal ganglia in Parkinson's disease during rhythm perception. (ekstern lenke)
• Geir Olve Skeie; Per K. Lunde; Ole M. Sejersted et al. (2001). Autoimmunity against the ryanodine receptor in myasthenia gravis. (ekstern lenke)
• Berit Vik; Geir Olve Skeie; Eirik Vikane et al. (2018). Effects of music production on cortical plasticity within cognitive rehabilitation of patients with mild traumatic brain injury. (ekstern lenke)
• Espen Homleid Alseth; Hanne Linda Nakkestad; Jan Harald Aarseth et al. (2009). Interleukin-10 promoter polymorphisms in myasthenia gravis. (ekstern lenke)
• Sander Johan Aarli; Tarek Mazzawi; Geir Olve Skeie (2015). En kvinne med kraftsvikt i armer og bein. (ekstern lenke)
• Geir Olve Skeie; Åse Mygland; S Treves et al. (2003). Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro. (ekstern lenke)
• Halvor Næss; Liv Hammersvik; Geir Olve Skeie (2009). Aphasia among Young Patients with Ischemic Stroke on Long-term Follow-up. (ekstern lenke)
• Fredrik Romi; Geir Olve Skeie; Christian A. Vedeler et al. (2000). Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. (ekstern lenke)
• Bente Skeie; Geir Olve Skeie; Per Øyvind Enger et al. (2011). Gamma Knife Surgery in Brain Melanomas: Absence of Extracranial Metastases and Tumor Volume Strongest Indicators of Prolonged Survival. (ekstern lenke)
• Espen Homleid Alseth; Angelina Maniaol; Ahmed Elsais et al. (2011). Investigation for RAPSN and DOK-7 mutations in a cohort of seronegative myasthenia gravis patients. (ekstern lenke)
• Nils Erik Gilhus; Jone Furulund Owe; Jana Midelfart Hoff et al. (2011). Myasthenia gravis; a review of available treatment approaches. (ekstern lenke)
• Hai-Feng Li; Yu Hong; Xu Zhang et al. (2016). Gene polymorphisms for both auto-antigen and immune-modulating proteins are associated with the susceptibility of autoimmune myasthenia gravis. (ekstern lenke)
• Geir Olve Skeie (2000). Skeletal muscle titin: physiology and pathophysiology. (ekstern lenke)
• Geir Olve Skeie; Johan Arild Aarli; Roald Matre et al. (1997). Titin antibody positive myasthenia gravis patients have a cellular immune response against the main immunogenic region of titin. (ekstern lenke)
• Geir Olve Skeie; JP Pandey; Johan Arild Aarli et al. (1997). Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes. (ekstern lenke)
• Ketil K Sund; Geir Olve Skeie; Nils Erik Gilhus et al. (1997). Diagnostikk av thymom og thymusatrofi hos pasienter med myasthenia gravis. (ekstern lenke)
• Cochavit Elefant; Felicity A. Baker; Meir Lotan et al. (2012). The Effect of Group Music Therapy on Mood, Speech, and Singing in Individuals with Parkinson's Disease - A Feasibility Study. (ekstern lenke)
• Brage Brakedal; Ole-Bjørn Tysnes; Geir Olve Skeie et al. (2014). The factor structure of the UPDRS motor scores changes during early Parkinson's disease. (ekstern lenke)
• Guttorm Raknes; Geir Olve Skeie; Nils Erik Gilhus et al. (1998). FcgRIIA and RIIIB polymorphisms in myasthenia gravis. (ekstern lenke)
• Geir Olve Skeie; PT Bentsen; A Freiburg et al. (1998). Cell-mediated immune response against titin in myasthenia gravis; evidence for the involvment of Th1 and Th2 cells. (ekstern lenke)
• Nils Erik Gilhus; Fredrik Robert Romi; Yu Hong et al. (2018). Myasthenia gravis and infectious disease. (ekstern lenke)
• Yu Hong; Paraskevi Zisimopoulou; Nikolaos B. Trakas et al. (2017). Multiple antibody detection in `seronegative? myasthenia gravis patients. (ekstern lenke)
• Geir Olve Skeie; Slobodanka Apostolski; Amelia Evoli et al. (2006). Guidelines for the treatment of autoimmune neuromuscular transmission disorders. (ekstern lenke)
• Haakon Berven; Simon Ulvenes Kverneng; Erika Sheard et al. (2023). NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease. (ekstern lenke)
• Irene Hana Flønes; Erika Fernandez-Vizarra; Maria Lykouri et al. (2017). Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage. (ekstern lenke)
• Johan Arild Aarli; Geir Olve Skeie; Åse Mygland et al. (1998). Muscle striation antibodies in myasthenia gravis; diagnostic and functional significance. (ekstern lenke)
• Per Øyvind Enger; Geir Olve Skeie; Frits Alan Thorsen et al. (2010). Gamma knife surgery of meningiomas involving the cavernous sinus: long-term follow-up of 100 patients. (ekstern lenke)
• Johan Arild Aarli; Nils Erik Gilhus; Fredrik Romi et al. (2008). Titin and ryanodine receptor antibodies and neurmuscular involvement in myasthenia gravis. (ekstern lenke)
• Sidsel Marit Bragstad; Marianne Flatebø; Gerd Karin Natvig et al. (2018). Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study. (ekstern lenke)
• Brage Brakedal; Christian Dölle; Frank Riemer et al. (2022). The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. (ekstern lenke)
• Fredrik Romi; Nils Erik Gilhus; Jan Erik Varhaug et al. (2002). Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis. (ekstern lenke)
• Fredrik Romi; Geir Olve Skeie; Johan Arild Aarli et al. (2000). The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. (ekstern lenke)
• Steven Paul Luckman; Geir Olve Skeie; Geir Helgeland et al. (2006). Effects of myasthenia gravis patient sera on human myoblast cultures. (ekstern lenke)
• Geir Olve Skeie; A Freiburg; B Kolmerer et al. (1998). Titin transcripts in thymoma. (ekstern lenke)
• Bente Sandvei Skeie; Per Øyvind Enger; Jonathan Knisely et al. (2020). A simple score to estimate the likelihood of pseudoprogression vs. recurrence following stereotactic radiosurgery for brain metastases: The Bergen Criteria. (ekstern lenke)
• Simon Ulvenes Kverneng; Kjersti Eline Stige; Haakon Berven et al. (2025). Mitochondrial complex I deficiency occurs in skeletal muscle of a subgroup of individuals with Parkinson’s disease. (ekstern lenke)
• Sissel Evy Monstad; Lars Drivsholm; Geir Olve Skeie et al. (2008). CRMP5 antibodies in patients with small-cell lung cancer or thymoma. (ekstern lenke)
• Fredrik Romi; Nils Erik Gilhus; Jan Erik Varhaug et al. (2003). Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis. (ekstern lenke)
• Bente Sandvei Skeie; Per Øyvind Enger; Jeremy Christopher Ganz et al. (2013). Gamma knife surgery of colorectal brain metastases: a high prescription dose of 25 Gy may improve growth control. (ekstern lenke)
• Johan Arild Aarli; Fredrik Romi; Geir Olve Skeie et al. (2003). Myasthenia gravis in individuals over forty. (ekstern lenke)
• Kristian Varden Gjerde; Bernd Mueller; Geir Olve Skeie et al. (2018). Hyposmia in a simple smell test is associated with accelerated cognitive decline in early Parkinson's disease. (ekstern lenke)
• Berit Vik; Geir Olve Skeie; Karsten Specht (2019). Neuroplastic effects in patients with traumatic brain injury after music-supported therapy. (ekstern lenke)
• Cochavit Elefant; Meir Lotan; Felicity A. Baker et al. (2012). Effects of music therapy on facial expression of individuals with Parkinson's disease: A pilot study. (ekstern lenke)
• Torbjørn Austveg Strømsnes; Morten Lund-Johansen; Geir Olve Skeie et al. (2023). Growth dynamics of incidental meningiomas: A prospective long-term follow-up study. (ekstern lenke)
• Bernd Mueller; J. Assmus; J. P. Larsen et al. (2013). Autonomic symptoms and dopaminergic treatment in de novo Parkinson's disease. (ekstern lenke)

Medieintervju

• Simen Krogstie Lagesen; Geir Olve Skeie (2013). Lydverket 25.06.2013. Hva skjer når vi skrur opp volumet og hører på høy musikk?. (ekstern lenke)

Deltakelse i radio eller TV

• Simen Krogstie Lagesen; Geir Olve Skeie (2010). Schrødingers Katt, NRK: Musikk - magisk medisin. (ekstern lenke)

Doktorgradsavhandling

• Geir Olve Skeie (1998). Autoimmunity against titin and ryanodine receptor in myasthenia gravis. Clinical and immunological aspects. (ekstern lenke)
• Kjetil Vikene; Karsten Specht; Geir Olve Skeie (2019). Complexity in Rhythm and Parkinson’s disease: Cognitive and Neuronal Correlates. (ekstern lenke)

Konferanseabstrakt

• Espen Homleid Alseth; Hanne Linda Nakkestad; Jan Harald Aarseth et al. (2009). Interleukin-10 promoter polymorphisms in myasthenia gravis. (ekstern lenke)

Konferanseposter

• Kristian Varden Gjerde; Bernd Müller; Geir Olve Skeie et al. (2018). Hyposmia and cognitive decline in early Parkinson's disease. (ekstern lenke)
• Torbjørn Austveg Strømsnes; MAZIAR BEHBAHANI; Geir Olve Skeie et al. (2021). Long term results following Repeat Gamma Knife Surgery for Incompletely obliterated Arteriovenous Malformations after the first Gamma Knife treatment. (ekstern lenke)
• Sunniva Ulstein Kayser; Wolfgang Schmid; Minna Hynninen et al. (2022). DysfaSing! Music therapy pilot study to adress dysphagia cognitve function and psychological well-being in early stage of Huntington Disease. (ekstern lenke)

Konferanseforedrag

• Bente Sandvei Skeie; Per Øyvind Enger; Geir Olve Skeie et al. (2001). Gamma Knife Radiosurgery of meningiomas involving the cavernous sinus. (ekstern lenke)
• Fredrik Romi; Nils Erik Gilhus; Jan Erik Varhaug et al. (2001). Thymectomy and muscle autoantibodies in myasthenia gravis. (ekstern lenke)
• Fredrik Romi; Lars Bø; Geir Olve Skeie et al. (2002). Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with co-stimulatory molecules. (ekstern lenke)
• Torbjørn Austveg Strømsnes; Morten Lund-Johansen; Geir Olve Skeie et al. (2022). Growth Dynamics of Incidental meningiomas. A 10 year prospective study. (ekstern lenke)
• Torbjørn Austveg Strømsnes; Morten Lund-Johansen; Geir Olve Skeie et al. (2021). Growth Dynamics of Incidental meningiomas. A 10 year prospective study. (ekstern lenke)
• Simen Krogstie Lagesen; Geir Olve Skeie; Karsten Specht et al. (2013). Musikk, terapi og nevrologiske sykdommer. (ekstern lenke)

Vitenskapelig bokkapittel

• Geir Olve Skeie; Johan Arild Aarli; Roald Matre et al. (1997). Myasthenia gravis patients have a cellular immune response against titin. (ekstern lenke)
• Geir Olve Skeie; S Apostolski; Amelia Evoli et al. (2011). Autoimmune neuromuscular transmission disorders. (ekstern lenke)
• Geir Olve Skeie; Slobodanka Apostolski; Amelia Evoli et al. (2006). Autoimmune neuromuscular conduction disorders. (ekstern lenke)
• S. Appiah-Boadu; Johan Arild Aarli; Geir Olve Skeie et al. (1997). Accessory molecule expression in human thymomas and thymus. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Anna Hermanrud; Geir Olve Skeie (2011). Musikkterapi innen nevrorehabilitering - med vekt på hvordan plastisitet kan utnyttes :. (ekstern lenke)
• Nils Erik Gilhus; Geir Olve Skeie; Fredrik Robert Romi et al. (2016). Myasthenia gravis - Autoantibody characteristics and their implications for therapy. (ekstern lenke)
• Kjersti Eline Stige; Simon Ulvenes Kverneng; Soumya Sharma et al. (2024). The STRAT-PARK cohort: A personalized initiative to stratify Parkinson's disease. (ekstern lenke)
• Geir Olve Skeie; Harald Aurlien; Juliane S. Müller et al. (2006). Unusual features in a boy with the rapsyn N88K mutation. (ekstern lenke)

Populærvitenskapelig artikkel

• Wolfgang Schmid; Geir Olve Skeie; Maren Ek Knudsen et al. (2015). Musikk som terapi for ALS. (ekstern lenke)

Rettelse i tidsskrift

• Yu Hong; Geir Olve Skeie; Paraskevi Zisimopoulou et al. (2019). Retraction Note to: Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms (Journal of Neurology, (2017), 264, 5, (955-962), 10.1007/s00415-017-8478-z). (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin